Literature DB >> 2738591

Influence of fluctuations of plasma large neutral amino acids with normal diets on the clinical response to levodopa.

J G Nutt1, W R Woodward, J H Carter, T L Trotman.   

Abstract

Plasma large neutral amino acids (LNAAs) compete with levodopa for entry into the brain. Fluctuations in plasma LNAA concentrations could therefore contribute to variability in clinical response to levodopa. The hourly plasma levodopa, plasma LNAAs and clinical response were investigated in 11 fluctuating Parkinsonian patients on a regular hospital diet. The fluctuations in plasma levodopa were 2 to 3 times greater than the fluctuations of plasma LNAAs. The correlation between clinical response and plasma levodopa was substantially improved in only one patient by considering plasma LNAAs and calculating relative levodopa flux into brain. Although plasma LNAAs significantly increased during the day, the patients' clinical status did not uniformly deteriorate and mean afternoon clinical scores correlated better with mean plasma levodopa and levodopa flux than with mean plasma LNAAs. Minimum effective concentrations of levodopa for clinical response did not correlate with 9 am LNAA concentrations. It is concluded that in most patients, the relatively small variation in plasma LNAAs in comparison with the large variations in plasma levodopa indicates that fluctuations in LNAA are not an important contributor to the fluctuating response to levodopa.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2738591      PMCID: PMC1032296          DOI: 10.1136/jnnp.52.4.481

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  28 in total

1.  Synthetic amino acids and the nature of L-DOPA transport at the blood-brain barrier.

Authors:  L A Wade; R Katzman
Journal:  J Neurochem       Date:  1975-12       Impact factor: 5.372

2.  Inhibition of L-[18F]fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography.

Authors:  K L Leenders; W H Poewe; A J Palmer; D P Brenton; R S Frackowiak
Journal:  Ann Neurol       Date:  1986-08       Impact factor: 10.422

3.  Clinical and biochemical studies with controlled-release levodopa/carbidopa.

Authors:  J G Nutt; W R Woodward; J H Carter
Journal:  Neurology       Date:  1986-09       Impact factor: 9.910

4.  The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport.

Authors:  J G Nutt; W R Woodward; J P Hammerstad; J H Carter; J L Anderson
Journal:  N Engl J Med       Date:  1984-02-23       Impact factor: 91.245

5.  Kinetic constants for blood-brain barrier amino acid transport in conscious rats.

Authors:  L P Miller; W M Pardridge; L D Braun; W H Oldendorf
Journal:  J Neurochem       Date:  1985-11       Impact factor: 5.372

Review 6.  Neutral amino acid transport at the human blood-brain barrier.

Authors:  W M Pardridge; T B Choi
Journal:  Fed Proc       Date:  1986-06

7.  Effect of various oral protein doses on plasma neutral amino acid levels.

Authors:  S E Møller
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

8.  Influence of dietary protein on motor fluctuations in Parkinson's disease.

Authors:  J H Pincus; K Barry
Journal:  Arch Neurol       Date:  1987-03

9.  Levodopa pharmacokinetics and pharmacodynamics in fluctuating parkinsonian patients.

Authors:  J G Nutt; W R Woodward
Journal:  Neurology       Date:  1986-06       Impact factor: 9.910

10.  Normal plasma free amino acid values in adults: the influence of some common physiological variables.

Authors:  C R Scriver; D M Gregory; D Sovetts; G Tissenbaum
Journal:  Metabolism       Date:  1985-09       Impact factor: 8.694

View more
  14 in total

1.  Parkinson's Disease: Motor Fluctuations.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

Review 2.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  Levodopa-induced response fluctuations in patients with Parkinson's disease: strategies for management.

Authors:  Teus van Laar
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 4.  'The clocks that time us'--circadian rhythms in neurodegenerative disorders.

Authors:  Aleksandar Videnovic; Alpar S Lazar; Roger A Barker; Sebastiaan Overeem
Journal:  Nat Rev Neurol       Date:  2014-11-11       Impact factor: 42.937

Review 5.  Circadian and sleep disorders in Parkinson's disease.

Authors:  Aleksandar Videnovic; Diego Golombek
Journal:  Exp Neurol       Date:  2012-08-23       Impact factor: 5.330

6.  Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease.

Authors:  Aleksandar Videnovic; Charleston Noble; Kathryn J Reid; Jie Peng; Fred W Turek; Angelica Marconi; Alfred W Rademaker; Tanya Simuni; Cindy Zadikoff; Phyllis C Zee
Journal:  JAMA Neurol       Date:  2014-04       Impact factor: 18.302

Review 7.  Using liquid levodopa in the treatment of Parkinson's disease. A practical guide.

Authors:  M C Kurth
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

Review 8.  Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease.

Authors:  Dirk Deleu; Margaret G Northway; Yolande Hanssens
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 9.  Consequences of Circadian Disruption on Neurologic Health.

Authors:  Aleksandar Videnovic; Phyllis C Zee
Journal:  Sleep Med Clin       Date:  2015-09-26

10.  Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson's disease.

Authors:  Tuhin Virmani; Sirinan Tazan; Pietro Mazzoni; Blair Ford; Paul E Greene
Journal:  J Clin Mov Disord       Date:  2016-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.